PlumX Metrics
Embed PlumX Metrics

Peripheral B cells repress B-cell regeneration in aging through a TNF-α/IGFBP-1/IGF-1 immune-endocrine axis

Blood, ISSN: 0006-4971, Vol: 138, Issue: 19, Page: 1817-1829
2021
  • 26
    Citations
  • 0
    Usage
  • 27
    Captures
  • 3
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

Inflammatory and Immune Mechanisms in COPD: Current Status and Therapeutic Prospects

Introduction Chronic Obstructive Pulmonary Disease (COPD) represents a diverse lung condition marked by persistent respiratory manifestations stemming from both airway and alveolar irregularities that result

Article Description

Loss of B lymphocyte regeneration in the bone marrow (BM) is an immunologic hallmark of advanced age, which impairs the replenishment of peripheral B-cell subsets and results in impaired humoral responses, thereby contributing to immune system dysfunction associated with aging. A better understanding of the mechanism behind this loss may suggest ways to restore immune competence and promote healthy aging. In this study, we uncover an immune-endocrine regulatory circuit that mediates cross-talk between peripheral B cells and progenitors in the BM, to balance B-cell lymphopoiesis in both human and mouse aging. We found that tumor necrosis factor α (TNF-α), which is increasingly produced by peripheral B cells during aging, stimulates the production of insulin-like growth factor-binding protein 1 (IGFBP-1), which binds and sequesters insulin-like growth factor 1 (IGF-1) in the circulation, thereby restraining its activity in promoting B-cell lymphopoiesis in the BM. Upon B-cell depletion in aging humans and mice, circulatory TNF-α decreases, resulting in increased IGF-1 and reactivation of B-cell lymphopoiesis. Perturbation of this circuit by administration of IGF-1 to old mice or anti–TNF-α antibodies to human patients restored B-cell lymphopoiesis in the BM. Thus, we suggest that in both human and mouse aging, peripheral B cells use the TNF-α/IGFBP-1/IGF-1 axis to repress B-cell lymphopoiesis. This trial was registered at www.clinicaltrials.gov as#NCT00863187.

Bibliographic Details

Dowery, Reem; Benhamou, David; Benchetrit, Eli; Harel, Ofer; Nevelsky, Alex; Zisman-Rozen, Simona; Braun-Moscovici, Yolanda; Balbir-Gurman, Alexandra; Avivi, Irit; Shechter, Arik; Berdnik, Daniela; Wyss-Coray, Tony; Melamed, Doron

American Society of Hematology

Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology; Medicine

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know